Page 175 - Tata Chemical Annual Report_2022-2023
P. 175

Integrated Annual Report 2022-23  01-83  84-192              193-365
               Integrated Report      Statutory Reports       Financial Statements
                                      Corporate Governance Report


    Details of Remuneration of Executive Directors for FY 2022-23      As per the practice, commission to the Directors is paid after the annual accounts are adopted by the Members at the AGM.
 (`)            The Company has not granted any stock options to its Directors.
 Name of the Director  Salary  Perquisites and  Commission*  Total       Details of Remuneration to Key Managerial Personnel other than Managing Director / Manager / Whole Time Director for
 Allowance  Remuneration  FY 2022-23
 Mr. R. Mukundan – Managing Director & CEO  3,53,52,328  31,75,926  4,35,00,000  8,20,28,254                (`)
 Mr. Zarir Langrana – Executive Director  1,90,00,352  54,43,432  1,85,00,000  4,29,43,784  Name of Key Managerial Personnel  Gross Salary Commission  Others  Total Remuneration
    *Commission relates to FY 2022-23, which will be paid during FY 2023-24  Mr. Nandakumar S. Tirumalai - Chief Financial Officer  2,79,86,130  - 12,61,065  2,92,47,195
      The above figures do not include provisions for encashable leave, gratuity and premium paid for group health insurance, as separate actuarial   Mr. Rajiv Chandan - Chief General Counsel & Company Secretary   1,90,96,503  - 24,18,789  2,15,15,292
 valuation / premium paid are not available.
    Service Contract, Severance Fees and Notice Period     Succession Plan     •    Ensuring timely receipt of dividend warrants/annual

 Terms of Agreement  Mr. R. Mukundan,  Mr. Zarir Langrana,      The Company believes that sound succession plans for the   reports/statutory notices by the shareholders of
                                                                       the Company.
 Managing Director & CEO  Executive Director  senior leadership are very important for creating a robust
                future for the Company. The NRC works along with the
 Period of Contract  5 years up to November 25, 2023  From April 1, 2023 up to February 29, 2024   Human Resources team of the Company for a structured      Meetings Held
 (i.e. till he attains the retirement age)  leadership succession plan.      During FY 2022-23, two (2) Meetings of the SRC were held
 Severance fees/notice period The Agreement may be terminated earlier, without any cause, by either Party by giving to   on the following dates:
 the other Party six months’ notice of such termination or the Company paying six months’      Retirement Policy for Directors
 remuneration which shall be limited to provision of Salary, Benefits, Perquisites, Allowances and       As per the Company’s policy, the Managing and Executive      •  June 21, 2022         •  March 3, 2023
 any pro-rated lncentive Remuneration (paid at the discretion of the Board, in lieu of such notice).      The necessary quorum was present for both the Meetings
                Directors retire at the age of 65 years, Non-Independent
 There is no separate provision for payment of severance fees.  Non-Executive Directors retire at the age of 70 years and   of the Committee.
                the retirement age for Independent Directors is 75 years.     Composition and Attendance
    Non-Executive Directors
                                                                                                         No.
                                                                                              No. of
     During FY 2022-23, the Company paid sitting fees of ` 30,000 per Meeting to the Non-Executive Directors for attending each   5.  Stakeholders Relationship Committee  Name of the Member  Category  Meetings held  of Meetings
 Meeting of the Board; Audit Committee and Nomination and Remuneration Committee; and ` 20,000 per Meeting for attending       The Stakeholders Relationship Committee (‘SRC’)   attended
 each Meeting of Stakeholders Relationship Committee; Meeting of Independent Directors; Corporate Social Responsibility   looks  into various  aspects of  interest  of  shareholders.
 Committee; Safety, Health, Environment and Sustainability Committee and Risk Management Committee. The Members   The Committee ensures cordial investor relations and   Ms. Vibha Paul Rishi   ID  2  2
                                                                   (Chairperson)
 had, at the AGM of the Company held on July 25, 2018 approved the payment of commission to the Non-Executive Directors   oversees the mechanism for redressal of investors’
 within the ceiling of 1% per annum of the net profits of the Company as computed under the applicable provisions of the Act.    grievances.  Mr. S. Padmanabhan  NED  2  2
 The said commission is decided each year by the Board of Directors and distributed amongst the Non-Executive Directors based   Mr. R. Mukundan  MD & CEO  2  2
 on their attendance and contribution at the Board and Committee Meetings. The Company also reimburses out-of-pocket      Terms of Reference  Mr. Zarir Langrana  ED  2  2
 expenses incurred by the Directors for attending the Meetings.
                The terms of reference of the SRC, inter alia, are as under:       ID - Independent Director; NED - Non-Executive Director; MD & CEO -
                                                                   Managing Director & Chief Executive Officer; ED - Executive Director
 Details of sitting fees paid and commission payable to the Non-Executive Directors for FY ended March 31, 2023 is      •   Resolving the grievances of the security holders;
 given below:
                •    Reviewing details of transfer of unclaimed      Status of Investor Complaints
 (`)                dividend/securities to the Investor Education and       The status of investor complaints as on March 31, 2023
 Name of the Director  Sitting Fees paid    Commission (for FY 2022-23    Protection Fund;  as reported under Regulation 13(3) of the SEBI Listing
 during FY 2022-23   payable in FY 2023-24)                        Regulations is as under:
                •     Reviewing the transfer, transmission, dematerialisation
 Mr. N. Chandrasekaran  1,80,000  @  of securities;
 Ms. Vibha Paul Rishi   6,00,000  60,00,000                        Pending as on April 1, 2022          0
 Mr. S. Padmanabhan    8,10,000  *     •    Reviewing measures taken for effective exercise of   Received during the year  80
 Ms. Padmini Khare Kaicker  5,00,000  60,00,000  voting rights by shareholders;  Resolved during the year  79
 Dr. C. V. Natraj  4,40,000  60,00,000     •    Reviewing adherence to the service standards in   Pending as on March 31, 2023  1
 Mr. K. B. S. Anand  5,50,000  50,00,000  respect of various services being rendered by the
 Mr. Rajiv Dube   2,60,000  50,00,000  Registrar & Share Transfer Agent;      The complaints have been resolved to the satisfaction
 Total  33,40,000  2,80,00,000                                     of the shareholders.  The correspondence identified
                •    Reviewing various measures and initiatives taken for   as  investor  complaints  are  letters  received  through
    @ As a policy, Mr. N. Chandrasekaran has abstained from receiving commission from the Company
                    reducing the quantum of unclaimed dividends; and  statutory/regulatory bodies.
      *In line with the internal guidelines of the Company, no payment is made towards commission to Mr. S. Padmanabhan, Non-Executive Director of the
 Company, who is in full-time employment with other Tata company





 172                                                                                                       173
   170   171   172   173   174   175   176   177   178   179   180